Gout and Crystalline Arthritis

Refractory Gout Is a Myth: Tips from an Expert

Samantha C. Shapiro, MD | July 22, 2022

At this EULAR 2022 session, one expert explains why he believes refractory gout is caused by mismanagement and discussed ways around treatment obstacles.

Imaging Modalities in Gout: How to Use them in Clinical Practice

Samantha C. Shapiro, MD | July 21, 2022

This EULAR 2022 session discussed the increasing role of imaging in the diagnosis of gout.

Treating to Target in Gout: The Trouble with Serum Urate

Samantha C. Shapiro, MD | July 21, 2022

New analyses of treat to target in gout may lead to revisions in some guidelines.

Gout Experts Share Insights Into a Variety of Challenging Gout Scenarios

Ruth Jessen Hickman, MD | June 14, 2022

Although the diagnosis and treatment of gout are sometimes straightforward, practitioners encounter challenges in patients with atypical presentations, as well as those with medically complex situations or refractory disease. Here, gout experts share insights into some of these scenarios. Flare in Hospitalized Patients When not contraindicated, the 2020 ACR Guideline for the Management of Gout…

Case Report: Lipoma Arborescens of the Knee

John Nawrocki, MD, Kevin Hess, DO, & Maryah Mansoor, MBBS | May 12, 2022

Lipoma arborescens is a rare, benign intra-articular lesion characterized by diffuse replacement of synovial tissue by mature adipocytes, causing a villous lipomatous proliferation of the synovial membrane.1 Typically, this is a monoarticular condition, with the knee being the most commonly affected although it has been rarely reported to occur in an oligo-/polyarticular fashion and in…

Another Way: RheumMadness 2022 DECT in Gout Scouting Report

MedStar Georgetown Washington Hospital Center: Leen Al Saleh, MD; Ajita Acharya, MD; Elena Obreja, MD; & Akrithi U. Garren, MD | February 14, 2022

Research has found dual-energy computed tomography (DECT) may be a non-invasive and cost-effective option to help rheumatologists more accurately diagnose gout.

A Unique Breed: RheumMadness 2022 Dalmatian Urate Scouting Report

University of Texas Southwestern Rheumatology Fellowship Program: Kubra Bugdayli, MD; Brett Capel, MD; Yusuf Chao, MD; Melissa DeFoe, MD; Daniel Emesiani, MD; Joad Eseddi, MD; Nagendra Pokala, MD; Komal Patel, MD; Bonnie Bermas, MD; Haidy Galous, MD; Andreas Reimold, MD; & Guillermo Andres Quiceno, MD | February 14, 2022

Dalmatians have defects in the renal tubular reabsorption of filtered urate and the hepatic conversion of uric acid to allantoin that may provide unique insights into uric acid homeostasis, with implications for the treatment and management of gout.

A Quick Reference Guide to Patient Education Materials on Gout

From the College | February 11, 2022

The following websites offer an abundance of options to help your patients understand their disease and learn to live with it. Several sites offer information in various languages, and for your patients who prefer audio-visual to print, one site has several educational videos. The ACR—Diseases and Conditions: Gout (Web page or PDF available in English…

Research Roundup: Abstract Data Presented at ACR Convergence 2021

Keri Losavio | February 11, 2022

The research presented at ACR Convergence 2021 had a broad scope. Below are details on three studies that addressed cardiovascular safety in treat-to-target strategies, phase 2 study results on the efficacy of tigulixostat and the impact of patient preference on treatment adherence. Take our quiz after you read this article. Treat to Target Abstract L06:…

Gout Management Recommendations from the ACR’s 2020 Guideline

From the College | February 11, 2022

The 2020 ACR Guideline for the Management of Gout is intended to provide guidance for the management of patients with gout, and includes recommendations on the indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations.1 The guideline includes 42 recommendations, of which 16 are strong….